Rossari Biotech Ltd

NSE: ROSSARI · BSE: 543213 · Chemicals & Petrochemicals · 43 announcements

Share price: ₹432.80
Market cap: ₹2,397 Cr
Revenue (annual): ₹2,396 Cr
Net profit (annual): ₹149.2 Cr
P/E (TTM): 15.7×Sector 35.5×
Promoter holding: 68.14%+0.00% QoQ
FII holding: 1.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17 Oct 2026 19:11 IST BSE

Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY

Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.

Key figure: Net profit ₹38.9 Cr · +5.4% YoY

Open full results → Read the filing ↗

27 Apr 2026 17:37 IST NSE

Financial Results

Rossari Biotech Q4 FY26 Results: Net Profit ₹46 Cr, Up 33.7% YoY

Rossari Biotech Ltd reported revenue from operations of ₹684.9 Cr (+18.2% YoY) and net profit of ₹46 Cr (+33.7% YoY) for Q4 FY26.

Key figure: Net profit ₹46 Cr · +33.7% YoY

Open full results → Read the filing ↗

27 Apr 2026 17:36 IST NSE

Financial Results

Rossari Biotech Financial Results

Rossari Biotech reported consolidated total income of ₹2,418.74 Crore for FY26. The Board recommended a final dividend of ₹0.50 per share (25%) and appointed Mr. Udeypaul Singh Gill as an Independent Director. Additionally, the company approved a new R&D facility in Navi Mumbai and an update on its capacity expansion project.

Value: ₹2,419 Cr

Open announcement → Read the filing ↗